|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/51 | |
| A61K 39/00 | |||
| A61K 31/436 |
| (11) | Number of the document | 3215192 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15857076.2 |
| Date of filing the European patent application | 2015-11-05 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/059350 |
| Date | 2015-11-05 |
| (87) | Number | WO 2016/073799 |
| Date | 2016-05-12 |
| (30) | Number | Date | Country code |
| 201462075864 P | 2014-11-05 | US | |
| 201462075866 P | 2014-11-05 | US |
| (72) |
O`NEIL, Conlin, US
GRISET, Aaron, P., US
ALTREUTER, David, H., US
|
| (73) |
Selecta Biosciences, Inc.,
65 Grove Street, Watertown, MA 02472,
US
|
| (54) | METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE |
| METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE |